Sector
Diagnostic devices
Device type
Point-of-care analyser, Class B
Services involved
Clinical research, quality and regulatory
Duration
14 months, protocol to submission
The challenge
Sensitivity and specificity, measured in the wrong room.
The existing evidence came from trained operators, controlled samples and a bench. The claim was for a ward, a clinic and a patient home. Those three settings differ in operator training, sample handling, ambient conditions and how long a result waits before it is read, and every one of those differences moves the number that matters.
What we did
Designed the study around the settings, not the device.
We built a protocol that enrolled in all three settings with the operators who would really use it, prespecified the agreement analysis against the reference method, and defined in advance what an unusable result was so that it could be counted rather than argued about. Ethics approvals ran in parallel across the participating sites, and the statistical analysis plan was fixed before the first sample.
What it took
The operator got better mid-study.
Agreement improved measurably over the first weeks at two sites. That is a training effect, and left unaddressed it inflates the performance claim. We had prespecified a learning-curve analysis, so we could show where performance stabilised and base the claim on the stable period, then feed the difference back into the instructions for use and the training material rather than into the marketing number.
The outcome
What came out of it.
- 480 participants enrolled across 4 sites and three use settings.
- Agreement with the reference method inside the pre-specified limits in all three settings.
- 2 deficiency questions at review, both administrative, none on clinical evidence.
- A learning-curve analysis that shaped the instructions for use rather than being discovered at review.
Services involved
The disciplines behind this programme.
Clinical research (CRO)
Protocol, ethics approvals, site execution, monitoring and the agreement analysis.
See the serviceQuality and regulatory affairs
Evidence strategy, technical file and submission.
See the serviceThey ran as one programme against a single plan, with one named programme lead accountable for the whole of it.
More examples
Other programmes.
Diagnostic
Wearable biosignal monitor
Therapeutic
Active therapy device
Drug delivery
Delivery device platform
Therapeutic
Implant-adjacent controller
Drug delivery
Connected adherence device
Placeholder figure, to be replaced with verified data before launch.
Next step
Working on something similar?
Tell us what you are building and where it is stuck.



